[1] HILTON D J, RICHARDSON R T, ALEXANDER W S, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes［J］. Proceedings of the National Academy of Sciences USA, 1998, 95(1):114-119.

[2] KILE B T, METCALF D, MIFSUD S, et al. Functional analysis of Asb-1 using genetic modification in mice［J］. Molecular and Cellular Biology, 2001, 21(18):6189-6197.

[3] CHUNG A S, GUAN Y J, YUAN Z L, et al. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II［J］. Molecular and Cellular Biology, 2005, 25(11):4716-4726.

[4] SEALE P, ISHIBASHI J, HOLTERMAN C, et al. Muscle satellite cell-specific genes identified by genetic profiling of MyoD-deficient myogenic cell［J］. Developmental Biology, 2004, 275(2):287-300.

[5] SCHIFFER J M, MALMSTROM R D, PARNELL J, et al. Model of the ankyrin and SOCS box protein, ASB9, E3 ligase reveals a mechanism for dynamic ubiquitin transfer［J］. Structure, 2016, 24(8):1248-1256.

[6] DIKS S H, BINK R J, VAN D E WATER S, et al. The novel gene asb11:a regulator of the size of the neural progenitor compartment［J］. The Journal of Cell Biology, 2006, 174(4):581 -592.

[7] DIKS S H, SARTORI DA SILVA MA, HILLEBRANDS J, et al. d-Asb11 is an essential mediator of canonical Delta-Notch signaling［J］. Nature Cell Biology, 2008, 10(10):1190-1198.

[8] SARTORI D S M, TEE J M, PARIDAEN J, et al. Essential role for the d-Asb11 cul5 box domain for proper notch signaling and neural cell fate decisions in vivo［J］. PLoS One, 2010, 5(11):e14023.

[9] TEE J M, SARTORI D S M, RYGIEL A M, et al. Asb11 is a regulator of embryonic and adult regenerative myogenesis［J］. Stem Cells and Development, 2012, 21(17):3091-3103.

[10] 胡君健. 肿瘤发生候选基因ASB11-1和心脏发育候选基因XIRP1的表达和功能初步研究［D］. 长沙:湖南师范大学, 2008.

    HU Junjian. Expression and functional analysis of tumorigenesis ASB11-1 and cardiogenesis XIRP1［D］. Changsha:Hunan Normal University, 2008.

[11] 杨建华. 人类ASB11基因在肌细胞分化中的调控作用［D］. 长沙:湖南师范大学, 2008.

    YANG Jianhua. Role of human ASB11 in myogenesis［D］. Changsha:Hunan Normal University, 2008.

[12] 孟和宝力高, 其其格, 额尔敦. DNA免疫的作用机制及影响因素［J］. 细胞与分子免疫学杂志, 2007, 23(7):682.

    MengHebaoligao, QI Qige, E Erdun. The mechanism of action and influence of DNA immunization［J］.Chinese Journal of Cellular and Molecular Immunology, 2007, 23(7): 682.

[13] WOLFF J A, DOWTY M E, JIAO S, et al. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle［J］. Journal of Cell Science, 1992, 103(4): 1249-1259.

[14] 刘淑颖, 陈雨欣, 王世霞, 等. DNA免疫技术在高质量单克隆抗体诱导开发中的应用进展［J］. 药学进展, 2017, 09(41):662-669.

    LIU Shuyin, CHEN Yuxin, WANG Shixia, et al. Progress in application of DNA immunization technique in R&D of high-quality monoclonal antibodies［J］. Progress Pharmaceutical Sciences, 2017, 09(41):662-669.

[15] 王和勇, 向阳, 唐亮, 等. 不同部位皮下注射DNA疫苗对小鼠体液免疫的影响［J］. 西南大学学报, 2008, 30(10):89-94.

    WANG Heyong, XIANG Yang, TANG Liang, et al. Effect of subcutaneous injection of DNA vaccine at different sites on humoral immunity in mice［J］. Journal of Southwest University, 2008, 30(10):89-94.

[16] 楚琰, 吴兴安. DNA疫苗及其免疫途径的研究进展［J］. 中国医药生物技术, 2010, 5(04):285-288.

    CHU Yan, WU Xingan. Research progress of DNA vaccine and it’s immune pathway［J］. Chinese Medicinal Biotechnology, 2010, 5(04):285-288.

[17] 姜永萍, 张洪波, 步志高, 等. 表达载体pCAGGS显著增强禽流感DNA疫苗的免疫保护效果［J］. 中国农业科学, 2006, 39(4):825-830.

    JIANG Yongping, ZHANG Hongbo, BU Zhigao, et al. Enhanced protective efficacy of avian influenza DNA vaccine with expressive vector pCAGGS［J］. Scientia Agricultura Sinica, 2006, 39(4):825-830.

[18] 刘丽梅, 陈宗涛, 高娜, 等. 利用DNA免疫技术制备抗登革2型病毒NS2B蛋白多克隆抗体［J］. 第三军医大学学报, 2010, 32(4):327-330.

    LIU Limei, CHEN Zongtao, GAO Na, et al. Preparation of polyclonal antibodies against NS2B of dengue virus serotype 2 by immunization with DNA［J］. Acta Academiae Medicinae Militaris Tertiae, 2010, 32(4):327-330.

[19] WOLFF J A, MALONE R W, WILLIAMS P, et al. Direct gene transfer into mouse muscle in vivo［J］. Science, 1990, 247(4949):1465-1468.

[20] TOKUOKA M, MIYOSHI N, HITORA T, et al. Clinical significance of ASB9 in human colorectal cancer［J］. International Journal of Oncology, 2010, 37(5): 1105-1111.